SSI Diagnostica A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.1% 2.3% 2.3% 0.7% 0.7%  
Credit score (0-100)  69 64 63 95 94  
Credit rating  A BBB BBB AA AA  
Credit limit (mDKK)  0.0 0.0 0.0 96.9 120.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  170 313 529 316 203  
Gross profit  170 313 529 88.3 107  
EBITDA  36.1 96.0 200 10.4 53.5  
EBIT  36.1 96.0 200 -5.0 24.9  
Pre-tax profit (PTP)  24.8 80.0 251.4 26.5 -108.1  
Net earnings  24.8 80.0 251.4 38.1 -126.8  
Pre-tax profit without non-rec. items  36.1 96.0 200 26.5 -108  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 58.0 87.8  
Shareholders equity total  98.2 395 690 1,016 1,248  
Interest-bearing liabilities  0.0 0.0 0.0 1,481 1,390  
Balance sheet total (assets)  290 843 999 3,185 2,723  

Net Debt  0.0 0.0 0.0 1,472 1,370  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  170 313 529 316 203  
Net sales growth  4.4% 84.1% 68.9% -40.2% -35.8%  
Gross profit  170 313 529 88.3 107  
Gross profit growth  4.4% 84.1% 68.9% -83.3% 21.6%  
Employees  0 0 0 125 112  
Employee growth %  0.0% 0.0% 0.0% 0.0% -10.4%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  290 843 999 3,185 2,723  
Balance sheet change%  -2.3% 190.6% 18.5% 218.8% -14.5%  
Added value  36.1 96.0 200.0 -5.0 53.5  
Added value %  21.2% 30.7% 37.8% -1.6% 26.4%  
Investments  0 0 0 191 -2  

Net sales trend  1.0 2.0 3.0 -1.0 -2.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  21.2% 30.7% 37.8% 3.3% 26.4%  
EBIT %  21.2% 30.7% 37.8% -1.6% 12.3%  
EBIT to gross profit (%)  21.2% 30.7% 37.8% -5.6% 23.2%  
Net Earnings %  14.6% 25.6% 47.6% 12.0% -62.5%  
Profit before depreciation and extraordinary items %  14.6% 25.6% 47.6% 16.9% -48.4%  
Pre tax profit less extraordinaries %  21.2% 30.7% 37.8% 8.4% -53.3%  
ROA %  12.3% 16.9% 21.7% 9.2% 7.3%  
ROI %  12.3% 16.9% 21.7% 10.9% 8.3%  
ROE %  27.3% 32.4% 46.3% 4.5% -11.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 31.9% 45.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 681.5% 713.3%  
Relative net indebtedness %  0.0% 0.0% 0.0% 678.4% 703.2%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 14,198.0% 2,559.1%  
Gearing %  0.0% 0.0% 0.0% 145.8% 111.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 22.3% 22.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 1.9 7.2  
Current Ratio  0.0 0.0 0.0 1.9 7.6  
Cash and cash equivalent  0.0 0.0 0.0 9.8 20.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 33.1 64.4  
Trade creditors turnover (days)  0.0 0.0 0.0 44.4 138.9  
Current assets / Net sales %  0.0% 0.0% 0.0% 466.4% 496.1%  
Net working capital  0.0 0.0 0.0 717.9 873.8  
Net working capital %  0.0% 0.0% 0.0% 227.1% 430.9%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 3 2  
Added value / employee  0 0 0 -0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 -0 0  
Net earnings / employee  0 0 0 0 -1